Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123511A2 Dosing regimens for the treatment of cancer
11/01/2007WO2007123468A1 Polymer-based anti-cancer agents
11/01/2007WO2007123465A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
11/01/2007WO2007123403A1 Improved treatment of cystic fibrosis
11/01/2007WO2007123400A1 Vaccine against nicotine addiction
11/01/2007WO2007123338A1 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
11/01/2007WO2007123274A1 Novel marker for sensitivity against sulfonamide compound
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007123234A1 Antiepileptic action enhancer
11/01/2007WO2007123233A1 Gene associated with arteriosclerotic disease, and use thereof
11/01/2007WO2007123225A1 Oxadiazolidinedione compound
11/01/2007WO2007123187A1 Pharmaceutical composition for conformational disease
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123153A1 Capsule for oral administration
11/01/2007WO2007123126A1 Agent for improving decreased exercise tolerance in chronic heart failure
11/01/2007WO2007123027A1 Anti-cancer agent comprising cyathane derivative
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122970A1 Ligand capable of binding to nuclear receptor
11/01/2007WO2007122813A1 Solid preparation for oral application
11/01/2007WO2007122812A1 Therapeutic agent for inflammatory bowel disease
11/01/2007WO2007122801A1 Gip secretion inhibitor
11/01/2007WO2007122686A1 Benzimidazole compounds
11/01/2007WO2007122637A1 Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
11/01/2007WO2007122634A2 Pyrimidinediones as tyrosine kinase inhibitors
11/01/2007WO2007122510A2 Asymmetric membranes for drug delivery devices
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122478A2 Multiple unit compositions
11/01/2007WO2007122466A1 Pyridine[3,4-b]pyrazinones
11/01/2007WO2007122411A1 Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
11/01/2007WO2007122410A1 Pyrimidine derivatives as pi3k inhibitors
11/01/2007WO2007122402A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases
11/01/2007WO2007122401A1 Imidazole derivatives for use as edg-1 antagonists
11/01/2007WO2007122382A2 Lycopene for the treatment of metabolic dysfunction
11/01/2007WO2007122369A2 Novel tumour suppressor
11/01/2007WO2007122274A1 Acetylcholinesterase-inhibiting compounds for treating alzheimer's disease
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
11/01/2007WO2007122241A1 Compounds which potentiate ampa receptor and uses thereof in medicine
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007122212A1 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles
11/01/2007WO2007122199A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007WO2007122190A1 Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007122165A1 Novel compounds
11/01/2007WO2007122156A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007WO2007122104A1 Dicarboxamide derivatives
11/01/2007WO2007122103A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007WO2007122084A1 Layout of power semiconductor contacts on a cooling surface
11/01/2007WO2007122015A1 Tolterodine beads
11/01/2007WO2007121988A1 Personalizing cancer chemotherapy based on methylation and germ-line mutational analysis of brca-1
11/01/2007WO2007121963A1 Methods for interfering with disease related to impaired mast cell activation
11/01/2007WO2007121949A1 Transdermal delivery system comprising sufentanil and its analogues
11/01/2007WO2007121933A1 Crystalline modification of cefuroximaxetil
11/01/2007WO2007121924A2 Bisadenosine compounds as adenosine a2a receptor agonists
11/01/2007WO2007121923A1 Purine derivatives as a2a receptor agonists
11/01/2007WO2007121921A2 Purine derivatives for use as adenosin a2a receptor agonists
11/01/2007WO2007121919A1 Purine derivatives with activity to the adenosine a2a receptor
11/01/2007WO2007121918A2 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists
11/01/2007WO2007121917A2 Purine derivatives as adenosine receptor activator
11/01/2007WO2007121916A2 Use of opioid receptor antagonists
11/01/2007WO2007121913A2 Pharmaceutical solution formulations for pressurised metered dose inhalers
11/01/2007WO2007121883A2 1,4:3,6-dianhydromannitol derivatives and use thereof
11/01/2007WO2007121807A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007121588A1 Treatment of atrial fibrillation
11/01/2007WO2007121584A1 Food product containing policosanols
11/01/2007WO2007121578A1 Indole amide derivatives as ep4 receptor antagonists
11/01/2007WO2007121546A1 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications
11/01/2007WO2007121545A1 S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions
11/01/2007WO2007121523A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
11/01/2007WO2007121513A1 Gels
11/01/2007WO2007121495A2 Method for diagnosing cardiovascular diseases
11/01/2007WO2007108936A3 N-substituted-azacyclylamines as histamine-3 antagonists
11/01/2007WO2007107305A3 Treatment of triple receptor negative breast cancer
11/01/2007WO2007106488A3 Modulators of gluconeogenesis
11/01/2007WO2007106022A3 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
11/01/2007WO2007104898A3 Method for reducing the odour caused by lipoamino acids in topical cosmetic and/or pharmaceutical formulations
11/01/2007WO2007104053A3 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
11/01/2007WO2007103727A3 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
11/01/2007WO2007103694A3 Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/01/2007WO2007103187A3 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
11/01/2007WO2007098967A3 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/01/2007WO2007098382A3 17-phosphorous steroid derivatives useful as progesterone receptor modulators
11/01/2007WO2007098118A9 Antineoplastic and curcumin derivatives and methods of preparation and use
11/01/2007WO2007097980A9 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
11/01/2007WO2007096151A3 Inhibitors of p38-kinase for treatment of pulmonary hypertension
11/01/2007WO2007095124A3 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
11/01/2007WO2007093880A3 Novel pyrone-indole derivatives and process for their preparation
11/01/2007WO2007093519A3 Ibandronate regimen for treating metastatic bone pain
11/01/2007WO2007092598A9 Novel neurological function of mpkci
11/01/2007WO2007092416A3 Melanin concentrating hormone receptor-1 antagonists
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007092198A3 Method of treating pediatric patients with corticosteroids
11/01/2007WO2007090553A3 Compounds useful as agonists of a2a adenosine receptors, cosmetic compositions with a2a agonists and a method for using the same
11/01/2007WO2007089907A3 Cationic steroid antimicrobial compositions and methods of use
11/01/2007WO2007088438A3 Benzisoxazole oxazolidinones as antibacterial agents
11/01/2007WO2007088034A3 Tuberous sclerosis treatment
11/01/2007WO2007087575A3 Compositions and methods for treating pulmonary hypertension
1 ... 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 ... 7860